Playback speed
10 seconds
AHA 2023 Insights: Target-HTN: Trial on the Safety and Efficacy of Lorundrostat (MLS-101) in Patients with Uncontrolled Hypertension
By
AHA 2023 Insights
FEATURING
Luke Laffin
By
AHA 2023 Insights
FEATURING
Luke Laffin
355 views
November 20, 2023
Comments 1
Login to view comments.
Click here to Login